SDEV AMEX
Stablecoin Development Corp.
1W: +402.0%
1M: +770.7%
3M: +442.0%
YTD: +398.7%
$7.48
+3.82 (+104.37%)
Weekly Expected Move ±76.6%
$-4
$2
$7
$13
$19
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$377.4M
52W Range0.8136-7.6493
Volume145,207,943
Avg Volume4,896,710
Beta0.09
Dividend$4.00
Analyst Ratings
No analyst coverage
Company Info
CEOMichael Kazley
Employees4
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2007-10-26
Websitestabledev.com
2000 Powell Street
Emeryville, CA 94608
US
Emeryville, CA 94608
US
1 510 899-8800
About Stablecoin Development Corp.
Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor. This enterprise was established on January 19, 2000, and its main office is situated in Emeryville, California.
Latest News
These High-Voltage Stocks Are Suddenly Impossible to Ignore
Stablecoin Development Corporation Reports Second Quarter 2026 Financial Results
SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly NovaBay Pharmaceuticals, Inc.) Stockholders
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Thursday's After-Market Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Rios David Garcia | 0 | — | 2026-09-02 | |
| Blynn Henry | 1,400,000 | — | 2026-07-15 | |
| Kazley Michael John | S-Sale | 24,720 | $1.09 | 2026-06-15 |
| Framework Ventures I | S-Sale | 24,720 | $1.09 | 2026-06-15 |
| R01 Fund LP | S-Sale | 24,720 | $1.09 | 2026-06-15 |